Contact
Please use this form to send email to PR contact of this press release:
Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer
TO:
Please use this form to send email to PR contact of this press release:
Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer
TO: